Buscar
01/10/2021
Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
Esquirol, A, Pascual, MJ, Kwon, M, Perez, A, Parody, R, Ferra, C, Cadenas, IG, Herruzo, B, Dorado, N, Hernani, R, Sanchez-Ortega, I, Torrent, A, Sierra, J, Martino, R. Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. BONE MARROW TRANSPLANTATION. 2021; 56(10)DOI:10.1038/s41409-021-01328-4. PMID:34059802. IF:5.174(Q2/3D).
30/09/2021
CEBPA bZip mutations: just a single shot
Sierra, J, Nomdedeu, JF. CEBPA bZip mutations: just a single shot. BLOOD. 2021; 138(13)DOI:10.1182/blood.2021011263. PMID:34591099. IF:25.669(Q1/1D).
01/09/2021
The EHA Research Roadmap: Malignant Myeloid Diseases
Dohner, H, Malcovati, L, Ossenkoppele, GJ, Hochhaus, A, Vannucchi, AM, Bullinger, L, Cervantes, F, Craddock, C, de Witte, T, Dohner, K, Dombret, H, Fenaux, P, Geissler, J, Germing, U, Guilhot, F, Harrison, C, Hellstrom-Lindberg, E, Passamonti, F, Sierra, J, Skoda, R, Wierzbowska, A. The EHA Research Roadmap: Malignant Myeloid Diseases. Hemasphere. 2021; 5(9)DOI:10.1097/HS9.0000000000000635. PMID:34476345. IF:8.300(Q1/2D).
01/09/2021
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
Larson, RA, Mandrekar, SJ, Huebner, LJ, Sanford, B, Laumann, K, Geyer, S, Bloomfield, CD, Thiede, C, Prior, TW, Dohner, K, Marcucci, G, Voso, MT, Klisovic, RB, Galinsky, I, Wei, AH, Sierra, J, Sanz, MA, Brandwein, JM, de Witte, T, Niederwieser, D, Appelbaum, FR, Medeiros, BC, Tallman, MS, Krauter, J, Schlenk, RF, Ganser, A, Serve, H, Ehninger, G, Amadori, S, Gathmann, I, Dohner, H, Stone, RM. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial. LEUKEMIA. 2021; 35(9)DOI:10.1038/s41375-021-01179-4. PMID:33654204. IF:12.897(Q1/1D).
01/08/2021
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
Kharfan-Dabaja, MA, Kumar, A, Ayala, E, Aljurf, M, Nishihori, T, Marsh, R, Burroughs, LM, Majhail, N, Al-Homsi, AS, Al-Kadhimi, ZS, Bar, M, Bertaina, A, Boelens, JJ, Champlin, R, Chaudhury, S, DeFilipp, Z, Dholaria, B, El-Jawahri, A, Fanning, S, Fraint, E, Gergis, U, Giralt, S, Hamilton, BK, Hashmi, SK, Horn, B, Inamoto, Y, Jacobsohn, DA, Jain, T, Johnston, L, Kanate, AS, Kansagra, A, Kassim, A, Kean, LS, Kitko, CL, Knight-Perry, J, Kurtzberg, J, Liu, H, MacMillan, ML, Mahmoudjafari, Z, Mielcarek, M, Mohty, M, Nagler, A, Nemecek, E, Olson, TS, Oran, B, Perales, MA, Prockop, SE, Pulsipher, MA, Pusic, I, Riches, ML, Rodriguez, C, Romee, R, Rondon, G, Saad, A, Shah, N, Shaw, PJ, Shenoy, S, Sierra, J, Talano, J, Verneris, MR, Veys, P, Wagner, JE, Savani, BN, Hamadani, M, Carpenter, PA. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. Transplantation And Cellular Therapy. 2021; 27(8)DOI:10.1016/j.jtct.2021.04.007. PMID:34304802. IF:(Q/D).
01/08/2021
Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group
Bueno, F, Solano, C, Vazquez, L, Gimenez, E, de la Camara, R, Albert, E, Rovira, M, Espigado, I, Calvo, CM, Lopez-Jimenez, J, Suarez-Lledo, M, Chinea, A, Esquirol, A, Perez, A, Bermudez, A, Saldana, R, Heras, I, Gonzalez-Huerta, AJ, Torrado, T, Batlle, M, Jimenez, S, Vallejo, C, Barba, P, Cuesta, MA, Duarte, R, Pinana, JL, Navarro, D. Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group. Transplant Infectious Disease. 2021; 23(4)DOI:10.1111/tid.13627. PMID:33908148. IF:2.867(Q3/6D).
01/08/2021
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study
Bento, L, Gutierrez, A, Novelli, S, Montoro, J, Pinana, JL, Lopez-Corral, L, Cabrero, M, Martin-Sancho, A, Gutierrez-Garcia, G, Ortiz-Moscovich, M, Bastos-Oreiro, M, Dorado, N, Perez, A, Hernani, R, Ferra, C, Parody, R, Garcia-Cadenas, I, Herrera, P, Rodriguez, G, Rodriguez, N, Martin, C, Yanez, L, Zanabili, J, Varela, MR, Lopez-Godino, O, Heras, I, Espanol, I, Martinez, C, Perez-Simon, JA, Solano, C, Sureda, A, Sierra, J, Sampol, A, Caballero, D. Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study. BONE MARROW TRANSPLANTATION. 2021; 56(8)DOI:10.1038/s41409-021-01264-3. PMID:33767400. IF:5.174(Q2/3D).
10/07/2021
Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4
Pallares, V, Nunez, Y, Sanchez-Garcia, L, Falgas, A, Serna, N, Unzueta, U, Gallardo, A, Alba-Castellon, L, Alamo, P, Sierra, J, Villaverde, A, Vazquez, E, Casanova, I, Mangues, R. Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4. JOURNAL OF CONTROLLED RELEASE. 2021; 335DOI:10.1016/j.jconrel.2021.05.014. PMID:34004204. IF:11.467(Q1/1D).